Sleep tech maker in the capital markets spotlight
A class-action-like suit claims Oura’s sleep tracking relies on AI estimates rather than physiological signals, arguing the ring cannot accurately determine sleep stages. The case cites a Nature study showing limited accuracy, while Oura defends its methodology and insists its data are scientifically grounded.
Oura has postponed its U.S. IPO plan, citing uncertainty in the IPO market. The health-tech ring maker had aimed to raise up to $2.2 billion and list on Nasdaq. Executives say the move reflects current macro headwinds, including rising bond yields and AI spending concerns.
Oil markets are adjusting amid renewed attacks near the Strait of Hormuz and coordinated fuel releases by the G7 and IEA. While some shipments resume, the risk to global supply remains elevated as tensions persist and sanctions pressure grows.
Prime Day has accelerated discounts on wearables, led by smart rings. The best options include the Oura Ring 4, RingConn gen 2, and Ultrahuman Ring Air, with prices slashed and subscriptions shaping value.
Global markets are volatile as AI-linked shares retreat amid funding risks. SK Hynix’s Solidigm reviews have been halted due to market conditions, while other AI infra players face investor scrutiny. The Kospi, Nasdaq, and European indices are all showing declines as inflation and rate expectations fuel selling.